Hospital
Howard County General Hospital, INC,
Howard County General Hospital, INC, was paid $4.47M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 50% of everything it billed.
33Billing provider infoHOWARD COUNTY GENERAL HOSPITAL, INC,
COLUMBIA, MD 21044
COLUMBIA, MD 21044
33aNPI1144291899assigned 01/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.47M
24GClaims105,953
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#10 of 69
Median peer was paid$870K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official AHMED, MOHAMMED controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,901 | $2.02M | |
| 2019 | 22,788 | $1.36M | |
| 2020 | 7,947 | $156K | |
| 2021 | 11,847 | $171K | |
| 2022 | 13,362 | $304K | |
| 2023 | 10,469 | $232K | |
| 2024incomplete | 9,639 | $231K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 50% | 775 | 585 | $2.25M |
| G0378 | Hospital observation service, per hour | 18% | 1,510 | 1,299 | $803K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 3,632 | 3,258 | $561K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.2% | 4,575 | 4,086 | $410K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 1,437 | 1,326 | $83K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.6% | 338 | 299 | $72K |
| 80053 | Comprehensive metabolic panel | 1.6% | 8,856 | 7,165 | $70K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,893 | 1,556 | $42K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,195 | 1,991 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,314 | 6,833 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,412 | 944 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,805 | 1,645 | $14K |
73 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 463 | $12K |
| J1815 | Injection, insulin, per 5 units | <1% | 371 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,359 | $7K |
| J3490 | Unclassified drugs | <1% | 1,477 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 392 | $6K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,374 | $6K |
| 87631 | <1% | 285 | $5K | |
| 81001 | <1% | 2,633 | $5K | |
| 85027 | <1% | 1,821 | $4K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 16 | $4K |
| 93971 | <1% | 29 | $4K | |
| 84484 | <1% | 3,508 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,178 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,033 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 418 | $3K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 92 | $3K |
| 83605 | <1% | 682 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 676 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,376 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 53 | $2K |
| 84703 | <1% | 1,292 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 63 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,061 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 17 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 417 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,550 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 751 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 83 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,295 | $899.82 |
| 97161 | <1% | 52 | $898.50 | |
| 94760 | <1% | 73 | $818.91 | |
| 81003 | <1% | 702 | $795.91 | |
| A9270 | Non-covered item or service | <1% | 26,246 | $779.97 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,405 | $716.37 |
| 86850 | <1% | 141 | $693.45 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 355 | $574.91 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 387 | $475.35 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 114 | $467.48 |
| 83690 | <1% | 1,391 | $442.84 | |
| 85610 | <1% | 1,113 | $425.23 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 144 | $423.19 |
| 87040 | <1% | 96 | $380.21 | |
| J7070 | Infusion, d5w, 1000 cc | <1% | 491 | $278.02 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 539 | $212.24 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 222 | $205.61 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 767 | $195.92 |
| 83880 | <1% | 245 | $138.18 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 345 | $133.98 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 104 | $131.90 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 81 | $125.90 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 165 | $125.17 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 18 | $99.94 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 34 | $86.79 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $72.93 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 664 | $49.09 |
| 83735 | <1% | 310 | $38.13 | |
| 85730 | <1% | 204 | $29.64 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 31 | $25.02 |
| 86900 | <1% | 102 | $23.09 | |
| 86901 | <1% | 102 | $23.09 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 56 | $18.50 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 32 | $8.83 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 55 | $0.14 |
| G1012 | Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program | 0% | 1,092 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 37 | $0.00 |
| 80143 | 0% | 40 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 26 | $0.00 |
| 80179 | 0% | 27 | $0.00 | |
| 82077 | 0% | 44 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 59 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 258 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 45 | $0.00 |
| 84132 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAHMED, MOHAMMED (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Merciful Healthcare Services LLC | Columbus, OH | $9.70M |
| Mohammed I Ahmed MD INC | Dublin, OH | $1.20M |
| Instacare PLLC | Morristown, TN | $1.09M |
| Antioch Medical and Hospital Supply, INC. | Antioch, CA | $437K |
| Center for Cardiovascular Care a Medical Corporation | San Jose, CA | $406K |
| Arthritis and Rheumatism Center INC | Toledo, OH | $332K |
| Kidney Center PLLC | Morristown, TN | $191K |
| Greenville Neuro Diagnostic Center, P.C. | Greenville, MS | $138K |
| Medlab Technologies LLC | Park Ridge, IL | $87K |
| Q Day Walk in Clinic and Spa, LLC | Plano, TX | $41K |
| Mercy Medical Transportation LLC | Columbus, OH | $20K |
| Critical Care Nurses LLC | Las Vegas, NV | $0.00 |
| Family Care Home Health & Hospice, LLC | Las Vegas, NV | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.